A tool used by the government for substance-use surveillance has consistently reported low rates of OUD. But the survey excluded a large group of Americans with OUD: people who take opioids as prescribed.
The New England Journal of Medicine: Search Results in Neurology/Neurosurgery
A 10-year-old boy was brought to the ED with a 4-day history of progressive bruising of the eyelids. Four weeks before presentation, a dry cough had developed that had increased in intensity over the previous week.
The New England Journal of Medicine: Search Results in Infectious Disease
A CD19-specific CAR T-cell therapy with intermediate affinity for CD19 produced a response in 77% of adults with refractory disease. Overall survival was 61% at 12 months, and serious toxic effects were rare.
The New England Journal of Medicine: Search Results in Hematology/Oncology
A 30-month-old boy was admitted to the hospital for the third time in 4 weeks because of fever. Evaluation was notable for lymphadenopathy, splenic lesions, pulmonary opacities, and leukocytosis. A diagnosis was made.
The New England Journal of Medicine: Search Results in Allergy/Immunology
In this open-label, proof-of-concept study in Brazil, bedaquiline showed substantial antimicrobial activity against Mycobacterium leprae in nine patients.
The New England Journal of Medicine: Search Results in Infectious Disease
A 50-year-old woman presented with a 5-year history of xanthogranulomas under her eyes. Laboratory studies were notable for thrombocytopenia and very high levels of low-density lipoprotein cholesterol.
The New England Journal of Medicine: Search Results in Dermatology
Uber advierte que, si la reforma se aprueba, sus tarifas y las de sus homólogas podrían aumentar entre un 40 y 50%.
Uber advierte que, si la reforma se aprueba, sus tarifas y las de sus homólogas podrían aumentar entre un 40 y 50%. Noticias sobre negocios
La plataforma anuncia una nueva opción que responde a las preguntas de los usuarios recuperando información de entradas e hilos de conversación.
La plataforma anuncia una nueva opción que responde a las preguntas de los usuarios recuperando información de entradas e hilos de conversación. Noticias sobre negocios
The selective estrogen-receptor degrader imlunestrant plus abemaciclib led to a median progression-free survival of 9.4 months among patients with ER-positive, HER2-negative breast cancer (vs. 5.5 months with imlunestrant alone).
The New England Journal of Medicine: Search Results in Hematology/Oncology
La herramienta que ofrece correcciones y comentarios en tiempo real a través de un lienzo ahora esta disponible para todos.
La herramienta que ofrece correcciones y comentarios en tiempo real a través de un lienzo ahora esta disponible para todos. Noticias sobre negocios
